Nanox Doubles Down on US Expansion with Healthcare IT Acquisition

NEW YORK, NY – November 19, 2025

Nanox Imaging Ltd. (Nasdaq: NNOX) is making a strategic move to bolster its U.S. market presence with the acquisition of VasoHealthcare IT from Vaso Corporation for up to $800,000. The deal, expected to close within weeks, aims to accelerate the deployment of Nanox’s AI-powered medical imaging solutions by integrating VHC IT’s existing infrastructure and expertise in healthcare IT implementation and support. The acquisition underscores a growing trend within the medical imaging sector toward vertically integrated solutions and streamlined deployment processes.

Accelerating Deployment and Reducing Friction

For Nanox, a company focused on preventative healthcare through advanced imaging and artificial intelligence, a key hurdle has been efficiently implementing its technology within the complex infrastructure of U.S. hospitals and healthcare providers. “The biggest challenge isn’t necessarily the technology itself, but the integration,” explained one industry analyst. “Getting AI-powered diagnostics into clinical workflows requires expertise in systems integration, data migration, and ongoing support.”

VasoHealthcare IT brings that expertise to the table. The company provides a suite of services, including healthcare systems integration, workflow optimization, and nationwide go-live support for medical imaging. By bringing these capabilities in-house, Nanox aims to significantly reduce deployment times and costs, and improve the overall customer experience. “This acquisition isn’t about acquiring revenue; it’s about removing friction,” said another observer familiar with the deal. “It’s about controlling the entire process from installation to ongoing support.”

Navigating a Competitive Landscape

The medical imaging market is fiercely competitive, with established giants like GE Healthcare, Siemens Healthineers, and Philips all vying for market share. These companies are heavily investing in AI and integrated solutions, recognizing the growing demand for more efficient and accurate diagnostics. Nanox, while smaller in scale, is attempting to differentiate itself through a unique business model and a focus on preventative care.

“Nanox is trying to disrupt the traditional medical imaging market by offering a more affordable and accessible solution,” said an expert in healthcare IT. “But that requires more than just innovative technology; it requires a robust infrastructure and a seamless integration with existing healthcare systems.”

The acquisition of VHC IT is a strategic step in that direction, allowing Nanox to offer a more comprehensive “scan to support” solution. While GE, Siemens and Philips offer similar bundled services, Nanox is positioning itself as an end-to-end solution provider that doesn’t simply sell machines but delivers integrated imaging and AI as a service.

Financial Considerations and Future Outlook

Nanox has faced scrutiny regarding its financial performance, with recent quarterly reports revealing ongoing net losses. The company's stock has experienced significant volatility, though it has recently seen some positive momentum with FDA clearances for its ARC system and AI algorithms. The acquisition of VHC IT is relatively small, with a potential price tag of up to $800,000 (including earnouts). However, it’s a strategically important move that aligns with Nanox's long-term growth strategy.

The company is actively deploying its FDA-cleared Nanox.ARC systems and demonstrating the clinical utility of its AI algorithms, such as HealthCCSng for cardiac imaging and HealthOST for bone health. These AI solutions analyze medical images to identify early signs of chronic diseases, providing clinicians with valuable insights and improving patient outcomes. Nanox is partnering with healthcare providers to implement these solutions in clinical settings, and the acquisition of VHC IT will accelerate this process. “The biggest challenge for Nanox is demonstrating that its technology delivers real value to healthcare providers,” said a venture capital investor. “If they can do that, they have the potential to disrupt the market.” The company’s focus on teleradiology services also provides a steady revenue stream and complements its imaging and AI solutions.

While the competitive landscape remains challenging, Nanox appears to be positioning itself for long-term growth by focusing on innovation, integration, and a commitment to preventative healthcare. The acquisition of VHC IT is a key step in that journey, allowing the company to deliver a more comprehensive and integrated solution to its customers.